Clinical Trials Browser

OTHER × Genitourinary × Clear all

NCT02555189 2026-04-22

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Phase 1/2 Terminated

52 enrolled 31 charts

Prostatic Neoplasms

NCT03436654 2026-04-22

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04917809 2026-04-22

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Phase 2 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05155501 2026-04-22

PARTIAL

Phase NA Recruiting

Prostatic Neoplasms

NCT05562791 2026-04-22

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Phase 1 Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT06172283 2026-04-22

Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase NA Recruiting

Prostatic Neoplasms

NCT07545694 2026-04-22

Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle

Urinary Bladder Neoplasms

NCT01590069 2026-04-21

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Phase 1 Active not recruiting

DermatologicGenitourinarySarcoma

Carcinoma, Renal Cell, Melanoma, Sarcoma, Osteosarcoma

NCT03595813 2026-04-21

IMMUNO-SUP

Phase NA Completed

GenitourinaryLymphoid

Lymphoma, Non-Hodgkin, Urologic Neoplasms

NCT04638088 2026-04-21

EMUPRO

Prostatic Neoplasms

NCT04946370 2026-04-21

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms

NCT06138496 2026-04-21

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Phase 2 Completed

Carcinoma, Renal Cell

NCT06284564 2026-04-21

A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT07225127 2026-04-21

CISTO2

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07541066 2026-04-21

Robotic Telesurgery in Urology

Phase NA Withdrawn

Prostatic Neoplasms

NCT07541911 2026-04-21

LaserSAFE

Phase NA Not yet recruiting

Margins of Excision, Adenocarcinoma, Prostatic Neoplasms

NCT02913196 2026-04-20

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Phase 1 Completed

Prostate Cancer Metastatic

NCT04393350 2026-04-20

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Phase 2 Active not recruiting

18 enrolled 12 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06378866 2026-04-20

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT07126548 2026-04-20

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07219147 2026-04-20

177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT07540260 2026-04-20

COSTAR-002

Phase NA Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02713269 2026-04-17

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Phase 2 Active not recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Sarcoma, Spinal Cord Compression, Thyroid Neoplasms

NCT05478694 2026-04-17

Outcomes of Focal Ablation for Prostate Cancer

Prostatic Neoplasms

NCT05766371 2026-04-17

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT06315595 2026-04-17

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

Prostatic Neoplasms

NCT06350734 2026-04-17

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Active not recruiting

Urinary Bladder Neoplasms

NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Phase 1 Recruiting

Testicular Neoplasms, Seminoma, Hearing Loss

NCT07234981 2026-04-17

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT07253987 2026-04-17

SURV-QoL

Phase NA Recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07322263 2026-04-17

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT07484971 2026-04-17

CLIQQC

Adenocarcinoma, Disease, Neoplasms, Prostatic Neoplasms

NCT07535541 2026-04-17

BioWEAR

Phase NA Not yet recruiting

Prostatic Neoplasms, Hot Flashes

NCT07535905 2026-04-17

REVIVE

Phase 2 Not yet recruiting

Hypogonadism, Prostatic Neoplasms

NCT07537010 2026-04-17

3D1015 Injection for Patients With mCRPC

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer, mCRPC

NCT00479128 2026-04-16

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Phase 1 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00567684 2026-04-16

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Phase NA Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Phase 1 Active not recruiting

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT03620786 2026-04-16

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

Prostatic Neoplasms

NCT04286386 2026-04-16

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

Active not recruiting

Prostate Adenocarcinoma

NCT05497024 2026-04-16

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Prostatic Neoplasms

NCT05663710 2026-04-16

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Phase 1/2 Recruiting

Carcinoma, Renal Cell

NCT06171139 2026-04-16

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms

NCT06347705 2026-04-16

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT07110038 2026-04-16

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Phase 2 Recruiting

Penile Squamous Cell Carcinoma (PSCC)

NCT07223424 2026-04-16

PSI-Immune

Phase 2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT07264088 2026-04-16

FOLLOW-UP

Not yet recruiting

100,000 enrolled

Prostatic Neoplasms

NCT07532902 2026-04-16

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Phase 1 Recruiting

Carcinoma, Transitional Cell

NCT07533344 2026-04-16

PSMA-MRI BX

Prostatic Neoplasms

NCT07534631 2026-04-16

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

Phase NA Completed

Urinary Bladder Neoplasms